Why do some patients respond well to the new cancer immunotherapies and others don't? The genetic components of the tumors or of the patients may contribute. Our work and that of other scientists now also suggest a role for differences in the makeup of the individuals' microbiome, the friendly bacteria that inhabit various parts of the body.